Abstract WP344: Total Healthcare Costs Before and After Stroke in Non-Valvular Atrial Fibrillation (NVAF) Patients Who Initiated Treatment With Rivaroxaban or Warfarin

Introduction: Healthcare expenditures remain unclear in NVAF patients initiating anticoagulation therapy. Objective: To compare total healthcare cost in pre- and post-stroke periods between rivarox...